Cegedim UK chief warns of changing needs of sales reps

15 January 2007

The job of the UK pharmaceutical sales representative is changing dramatically, evolving into a far more strategic and valuable account management position, according to Gareth Thomas, managing director of Cegedim UK, a specialist software firm. As such, the representative needs constant access to up-to-date information that provides insight into the targets of local divisions of the National Health Service.

However, without providing representatives with the right skills and information resources, Mr Thomas doubts if drugmakers can deliver the level of differential messaging required to meet the diverse requirements of different groups across the NHS.

Mr Thomas notes that "the traditional representative has honed the process of the three-product detail to a fine art. The skill set is familiar and proven. But, unfortunately, it is becoming increasingly irrelevant. What has been essentially a product-led detail must now evolve into the ability to discuss emerging NHS issues that reflect local, regional and central policy change."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight